Regulatory T Cells for Amyotrophic Lateral Sclerosis
Clinical trial NCT05695521 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05695521
- Sponsor
- Cellenkos, Inc.
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-04-03
- Primary completion
- 2026-05-01
- Enrollment
- 66
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.